RxSight (RXST) Free Cash Flow Growth (1y) (2021 - 2026)
Powered by 
Analysis
RxSight (RXST) Free Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 28.87% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 69.33% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 120.89% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 14.12% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 13.29% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 142.84% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -0.16% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -11.68% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -14.34% |
| 10 | RxSight | 265.13 Mn | -139.12 Mn | - | -94.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -94.39% |
| Mar 31, 2026 | -23.84% |
| Dec 31, 2025 | 55.88% |
| Sep 30, 2025 | -290.29% |
| Jun 30, 2025 | -6.54% |
| Mar 31, 2025 | 16.58% |
| Dec 31, 2024 | 48.37% |
| Sep 30, 2024 | 94.75% |
| Jun 30, 2024 | 40.76% |
| Mar 31, 2024 | 39.08% |
| Dec 31, 2023 | 30.42% |
| Sep 30, 2023 | 45.24% |
| Jun 30, 2023 | 41.09% |
| Mar 31, 2023 | -20.55% |
| Dec 31, 2022 | -56.44% |
| Sep 30, 2022 | -12.56% |
| Jun 30, 2022 | -24.23% |
| Mar 31, 2022 | -42.84% |
| Dec 31, 2021 | -3.67% |
| Sep 30, 2021 | -85.53% |